![]() |
市场调查报告书
商品编码
1830972
髋关节植入物市场Hip Implants Market |
髋关节植入物市场预计将从 2024 年的 73.7 亿美元扩大到 2031 年的 98 亿美元,预计 2024 年至 2031 年的复合年增长率为 4.1%。
市场洞察与分析师观点:髋关节植入物市场正经历快速成长,这得益于髋关节手术、髋关节损伤、骨关节炎和类风湿性关节炎病例的增加。此外,企业为保持竞争力而采取的策略性措施也推动着市场成长。例如,2023年8月,施乐辉(Smith & Nephew)在印度推出了初次和翻修髋关节置换术的OR3O双动系统。 OR3O采用施乐辉先进的承载面OXINIUM DH,该系统采用衬垫和专有的OXINIUM on XLPE,无需模组化钴铬衬垫和/或钴铬头球,从而降低了与合金相关的磨损和腐蚀风险。因此,旨在满足客户需求的创新技术显着成长,预计将为髋关节植入物市场预测带来新的趋势。
成长动力与挑战:根据骨关节炎行动联盟报告,骨关节炎是美国最常见的关节炎之一,影响近 3,250 万人,其中 43% 的人口在 2020 年年龄超过 65 岁。根据疾病管制与预防中心的数据,2020 年约有 23% 的美国人口患有关节炎。此外,加拿大关节炎研究中心估计,超过 600 万加拿大人患有骨关节炎,预计到 2040 年将上升到 1,050 万人。骨关节炎可导致髋部损伤和骨折,因为关节炎患者的骨密度通常低于非关节炎患者。
世界卫生组织 (WHO) 估计,2019 年全球 60 岁以上人口达 10 亿,预计到 2030 年将达到 14 亿,到 2050 年将达到 21 亿。预计在此期间,老年人口比例将从约 15% 增加到 24% 左右。欧盟统计局也报告称,2021 年欧洲 60 岁以上人口比例最高(20.8%)。此外,到 2050 年,除非洲外,所有地区 60 岁以上人口比例将超过 25%。因此,老年人口的增长导致各种骨科疾病的增加,例如髋部损伤、骨关节炎以及因跌倒和其他不幸事件导致的髋关节脱位,从而推动了髋关节植入物市场的成长。
策略洞察报告细分和范围:髋关节植入物市场按产品类型、材料、最终用户和地理分类。根据产品类型,市场分为全置换、部分置换、髋关节表面置换和髋关节翻修植入物。依材料,市场包括金属对聚乙烯、陶瓷对陶瓷、陶瓷对金属、陶瓷对聚乙烯等。按最终用户,市场细分为医院、骨科诊所、门诊手术中心等。从地域来看,市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、义大利、西班牙、俄罗斯和欧洲其他地区)、亚太地区(中国、日本、印度、韩国、澳洲和亚太其他地区)、中东和非洲(阿联酋、沙乌地阿拉伯、南非和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲其他地区)。
細項分析:依产品类型对髋关节植入物市场进行分析,包括股骨重建、髋臼重建、髋关节表面置换、髋关节翻修植入物、轴承和多孔金属技术以及全置换植入物。 2022年,全置换植入物细分市场占据髋关节植入物市场的最大份额,预计在2022年至2030年期间达到最高复合年增长率。
依材料分类,市场可分为金属-聚乙烯、陶瓷-陶瓷、陶瓷-金属和陶瓷-聚乙烯。 2022年,金属-塑胶髋关节植入物占据最大市场份额,预计在2022年至2030年期间的髋关节植入物市场中,其复合年增长率最高。该领域的成长得益于精准的疗效、耐用性和成本效益等优势。此外,併发症更少、技术进步和磨损颗粒减少等优势也推动了金属-塑胶髋关节植入物的需求。
按最终用户划分,市场可细分为医院、骨科诊所、门诊手术中心及其他。 2022年,医院市场占据最大市场份额,预计2022年至2030年期间的复合年增长率最高。医院髋关节植入手术数量的不断增加,正在推动全球该领域的成长。医院工作人员训练有素,熟悉手术期间或术后可能出现的併发症,这使其能够处理紧急情况并提供全面的患者护理。在医院环境下,手术报销流程也更方便、更容易管理。此外,全球医院数量的不断增长有望在预测期内保持该领域的主导地位,并支持髋关节植入市场的成长。
区域分析:从地理来看,髋关节植入物市场报告分为北美、欧洲、亚太地区、中东和非洲以及南美和中美。北美是全球髋关节植入物市场成长的最大贡献者。预计在2022年至2030年期间,亚太地区的髋关节植入物市场复合年增长率最高。髋关节植入物、产品发布以及运动相关髋关节损伤的发病率上升是推动美国市场成长的主要因素。根据威科健康公司(Wolters Kluwer Health, Inc.)发表的文章《髋关节骨折护理与国家系统》,美国每年约有25万至30万人因髋关节骨折住院。据估计,到2040年,约有50万人将因髋关节骨折而就医。美国骨科医师学会指出,65岁及以上的人尤其容易因家庭或社区环境中的跌倒而发生髋关节骨折。根据美国国家医学图书馆发表的《髋关节概述》一文,髋部骨折后第一年患者花费约4万美元,美国髋部骨折治疗总费用每年高达近170亿美元。因此,美国髋部骨折和损伤的发生率不断上升,以及治疗费用的上涨,是目前美国髋部植入物市场的趋势。
髋关节植入物市场报告范围行业发展和未来机会:髋关节植入物市场的主要参与者已经概述了各种策略,包括:
2022年8月,Exatech推出了全新的全髋关节置换系统,以Spartan柄和Logical杯为特色。 Spartan髋关节柄满足了当代患者的需求,并融合了最新的外科手术进展。 Logical杯是一款模组化髋臼系统,专为活动量大的患者设计,可提高医院和门诊手术中心的手术效率。 2022年9月,施乐辉(Smith & Nephew)在日本推出了初次和翻修髋关节置换术的OR3O双动系统。这种先进的承载表面OXINIUM DH用于其线性和专有的OXINIUM on XLPE聚乙烯插入件和股骨头。竞争格局和主要公司:髋关节植入物市场报告中提到的一些领先公司包括施乐辉、Exactech、Zimmer Biomet、Stryker Corporation、DJO Surgical (Enovis)、Medacta、Conformis、DePuy Orthopaedics、MicroPort Ortedics和Symbhopedics和Symbios。这些公司专注于地理扩张和新产品发布,以满足日益增长的全球消费者需求,并增强其特色产品组合。其国际影响力使其能够满足广泛的客户群,促进市场成长。
The hip implants market is projected to expand from US$ 7.37 billion in 2024 to US$ 9.80 billion by 2031, with an expected CAGR of 4.1% from 2024 to 2031.
Market Insights and Analyst Perspective:The hip implants market is experiencing rapid growth driven by an increase in hip surgeries, hip injuries, osteoarthritis, and rheumatoid arthritis. Additionally, strategic initiatives by companies to maintain competitiveness are propelling market growth. For example, in August 2023, Smith & Nephew introduced the OR3O Dual Mobility System in India for primary and revision hip arthroplasty. The OR3O features Smith & Nephew's advanced bearing surface, OXINIUM DH, which utilizes a liner and proprietary OXINIUM on XLPE, eliminating the need for a modular CoCr liner and/or CoCr head ball, thereby reducing wear and corrosion risks associated with the alloy. Consequently, a notable increase in innovative technologies aimed at meeting customer needs is expected to introduce new trends in the hip implants market forecast.
Growth Drivers and Challenges:As reported by the Osteoarthritis Action Alliance, osteoarthritis is one of the most prevalent forms of arthritis in the US, affecting nearly 32.5 million individuals, with 43% of this population being over 65 years old in 2020. According to the Centers for Disease Control and Prevention, approximately 23% of the US population had arthritis in 2020. Furthermore, Arthritis Research Canada estimates that over 6 million Canadians suffer from osteoarthritis, a figure projected to rise to 10.5 million by 2040. Osteoarthritis can lead to hip injuries and fractures, as patients with arthritis typically have lower bone density compared to those without the condition.
The World Health Organization (WHO) estimated that in 2019, there were 1 billion individuals aged over 60, a number expected to reach 1.4 billion by 2030 and 2.1 billion by 2050. The share of the geriatric population is anticipated to increase from approximately 15% to around 24% during this timeframe. Eurostat also reported that Europe had the highest percentage (20.8%) of individuals aged over 60 in 2021. Moreover, by 2050, all regions except Africa will have more than 25% of their populations aged over 60. Thus, the rise in the elderly population has led to an increase in various orthopedic conditions, such as hip injuries, osteoarthritis, and hip dislocations due to falls and other unfortunate events, contributing to the growth of the hip implants market.
Strategic Insights
Report Segmentation and Scope:The hip implants market is categorized by product type, material, end user, and geography. By product type, the market is divided into total replacement, partial replacement, hip resurfacing, and revision hip implants. By material, the market includes metal-on-polyethylene, ceramic-on-ceramic, ceramic-on-metal, ceramic-on-polyethylene, and others. By end user, the market is segmented into hospitals, orthopedic clinics, ambulatory surgical centers, and others. Geographically, the market is divided into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Segmental Analysis:The analysis of the hip implants market by product type includes femoral reconstruction, acetabular reconstruction, hip resurfacing, revision hip implants, bearing and porous metal technologies, and total replacement implants. In 2022, the total replacement implants segment held the largest share of the hip implants market and is expected to achieve the highest CAGR from 2022 to 2030.
By material, the market is categorized into metal-on-polyethylene, ceramic-on-ceramic, ceramic-on-metal, and ceramic-on-polyethylene. In 2022, the metal-on-plastic segment held the largest market share and is projected to experience the highest CAGR in the hip implants market forecast from 2022 to 2030. This segment's growth is driven by advantages such as precise outcomes, durability, and cost-effectiveness. Additionally, benefits like fewer complications, technological advancements, and reduced wear particles are boosting the demand for metal-on-plastic hip implants.
By end user, the market is segmented into hospitals, orthopedic clinics, ambulatory surgical centers, and others. In 2022, the hospital segment held the largest market share and is expected to record the highest CAGR from 2022 to 2030. The increasing number of hip implant surgeries in hospitals is driving growth in this segment globally. Hospital staff are well-trained and knowledgeable about potential complications during or after surgery, enabling them to manage emergencies and provide comprehensive patient care. Reimbursement processes for surgeries are also more accessible and manageable within hospital settings. Furthermore, the growing number of hospitals worldwide is likely to maintain the segment's dominance and support the growth of the hip implants market during the forecast period.
Regional Analysis:Geographically, the hip implants market report is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the global hip implants market growth. The Asia Pacific region is expected to exhibit the highest CAGR in the hip implants market forecast from 2022 to 2030. The rising incidence of hip implants, product launches, and sports-related hip injuries are primarily driving market growth in the US. According to the article "Hip Fracture Care and National Systems" published by Wolters Kluwer Health, Inc., approximately 250,000 to 300,000 individuals in the US are hospitalized for hip fractures each year. It is estimated that by 2040, around 500,000 people will seek medical attention for hip fractures. The American Academy of Orthopaedic Surgeons notes that individuals aged 65 and older are particularly susceptible to hip fractures due to falls in household or community settings. According to the article "Hip Overview" published in the National Library of Medicine, patients spend about US$ 40,000 in the first year following a hip fracture, with the total cost of hip fracture care in the US reaching nearly US$ 17 billion annually. Therefore, the increasing prevalence of hip fractures and injuries in the US, along with rising treatment costs, are current trends in the hip implants market in the US.
Hip Implants Market Report Scope
Industry Developments and Future Opportunities:Key players in the Hip Implants Market have outlined various strategies, including:
In August 2022, Exatech launched a new total hip arthroplasty system featuring the Spartan Stem and Logical Cup. The Spartan Hip Stem addresses contemporary patient needs and incorporates the latest surgical advancements. The Logical Cup is a modular acetabular system designed for highly active patients while facilitating efficient surgical processes in hospitals and ambulatory surgical centers.
In September 2022, Smith & Nephew introduced the OR3O Dual Mobility System for primary and revision hip arthroplasty in Japan. This advanced bearing surface, OXINIUM DH, is utilized for its linear and proprietary OXINIUM on XLPE for polyethylene inserts and femoral heads.
Competitive Landscape and Key Companies:Some of the leading companies featured in the hip implants market report include Smith & Nephew, Exactech, Zimmer Biomet, Stryker Corporation, DJO Surgical (Enovis), Medacta, Conformis, DePuy Orthopaedics, MicroPort Orthopedics, and Symbios. These companies are focusing on geographic expansion and new product launches to meet the increasing global consumer demand and enhance their specialty product portfolios. Their international presence enables them to cater to a broad customer base, facilitating market growth.